Molecular mechanisms in radiation-induced cell death of gynecologic cancer

放射诱导妇科癌症细胞死亡的分子机制

基本信息

  • 批准号:
    09671708
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

(I) Effects of cytokines and anticancer drugs on radiosensitivities of radiosensitive human cervical SCC cells. INFs and anti-Fas IgM enhanced radiation-induced cell death in the cervical SCC cells, while IL-1beta and TGF-beta1 inhibited the cell death dose-dependently. The inhibitory mechanisms by TGF-beta1, not by IL-1beta, were shown to be tissue-specific and cell cycle-dependent manners.(2) Establishment and characterization of radioresistant subclones derived from the human cervical SCC cells Radioresistant subolones were established and examined for anticancer drug-sensitivity tests. The result that the radioresistant cells had higher sensitivities to CDDP, SN38, or THP indicates that these drugs should be chosen for the patients with postirradiation recurrent cervical SCC.Expression cloning experiments of the radioresistant genes were tried in vain.(3) Establishment and characterization of anti cancer drug-resistant subclones derived from the human cervical SCC cells. Several drug-resistant subclones exhibited cross-resistances to several anticancer drugs and gamma-irradiation. Three CPA-resistant subclones were resistant to radiation-induced cell death. This suggests a possibility that CPA-induced apoptosis share common signaling pathways to radiation-induced apoptosis in the SCC cells. Our results indicate that acquired drug-resistance in cancer cells might be associated with acquisition of radioresistance ; and conversely this indicates that acquisition of radio-resistance in cancer cells might be associated with acquired drug-resistance. Results of the semi-quantitative RT-PCR analyses suggest a possibility that bcl-2 family gene products, c- myc, and beta-actin share some common apoptotic signals to human cervical SCC cells. Accordingly it is thus inferred that these mutations can be used for genetic markers to evaluate drug-resistance and/or radio-resistance in cervical cancer cells.
(I)细胞因子和抗癌药物对放射敏感的人宫颈鳞癌细胞放射敏感性的影响。INF和抗Fas IgM增强了宫颈鳞癌细胞辐射诱导的细胞死亡,而IL-1 β和TGF-β 1剂量依赖性地抑制细胞死亡。TGF-β 1而非IL-1 β的抑制机制显示出组织特异性和细胞周期依赖性。(2)人宫颈鳞状细胞癌放射抗性亚克隆的建立和鉴定放射抗性亚克隆被建立并用于抗癌药物敏感性试验。结果表明,放射抵抗细胞对顺铂、SN 38、THP等药物敏感性较高,提示放射后复发的宫颈鳞癌患者应选择这些药物治疗。(3)人宫颈鳞癌细胞抗肿瘤耐药亚克隆的建立及鉴定。几个耐药亚克隆对几种抗癌药物和γ射线表现出交叉耐药性。三个CPA抗性亚克隆对辐射诱导的细胞死亡具有抗性。这表明CPA诱导的细胞凋亡可能与辐射诱导的SCC细胞凋亡具有共同的信号通路。我们的研究结果表明,在癌细胞中获得的耐药性可能与获得的辐射抗性有关;相反,这表明在癌细胞中获得的辐射抗性可能与获得的耐药性有关。半定量RT-PCR分析的结果提示bcl-2家族基因产物、c-myc和β-actin可能与人宫颈SCC细胞共享一些共同的凋亡信号。因此,推断这些突变可用于遗传标记,以评估宫颈癌细胞的耐药性和/或放射抗性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tetsuji Tanaka,et al.: "Establishment and characterization of anticancer drug resistant subclones derived from human cervical squamous cell carcinoma" Cytomolecular Genetics.4 印刷中. (1999)
Tetsuji Tanaka 等人:“源自人宫颈鳞状细胞癌的抗癌药物耐药亚克隆的建立和表征”Cytomolecular Genetics.4 出版(1999 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANAKA Tetsuji其他文献

TANAKA Tetsuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANAKA Tetsuji', 18)}}的其他基金

Multidrug-resistance of cancer cells and their recovery by regulating expressions of DAP kinase-related molecules
癌细胞的多药耐药性及其通过调节DAP激酶相关分子表达的恢复
  • 批准号:
    20591959
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and clinical application of novel antiapoptotic factor produced from ovarian cancer cells
新型卵巢癌细胞抗凋亡因子的鉴定及临床应用
  • 批准号:
    18591843
  • 财政年份:
    2006
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular targeting therapy for anticancer drug-resistant cancer cells derived from uterus and ovary
子宫和卵巢来源的抗癌药物耐药癌细胞的分子靶向治疗
  • 批准号:
    17591752
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic study to establish molecular diagnosis and gene therapy for anticancer drug-resistant cancer cells
建立抗癌耐药癌细胞分子诊断和基因治疗的基础研究
  • 批准号:
    13470353
  • 财政年份:
    2001
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Expression cloning of anticancer drug-sensitivity-regulatory molecules in gynecologic malignancy
妇科恶性肿瘤抗癌药敏调节分子的表达克隆
  • 批准号:
    11671642
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

H2AX、STAT1蛋白表达调控体内外食管癌细胞放射敏感性的研究
  • 批准号:
    30870743
  • 批准年份:
    2008
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Acoustic Droplet Initiated Radiosensitivity of Hepatocellular Carcinoma
声液滴引发肝细胞癌的放射敏感性
  • 批准号:
    10648110
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident
开发快速剂量测定系统,用于快速评估大规模放射事件受害者的急性辐射暴露、个体放射敏感性和损伤
  • 批准号:
    10784562
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Prediction Model for Adverse Events Based on Radiosensitivity in Chemoradiotherapy for Lung Cancer
基于放射敏感性的肺癌放化疗不良事件预测模型
  • 批准号:
    23K14893
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of maternal diet on children's radiosensitivity
母亲饮食对儿童放射敏感性的影响
  • 批准号:
    22K12387
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic basis of individual radiosensitivity for medical radiation protection
医疗辐射防护个体放射敏感性的遗传基础
  • 批准号:
    22H03742
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Patient-derived organoids reveal rectal cancers develop radiosensitivity
患者来源的类器官揭示直肠癌产生放射敏感性
  • 批准号:
    10343663
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
Uncovering the mechanism of radiosensitivity mediated by the loss of Histone Deacetylase 3 in small-cell lung cancer
揭示小细胞肺癌中组蛋白脱乙酰酶 3 缺失介导的放射敏感性机制
  • 批准号:
    466522
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Studentship Programs
Public big database about in-vitro radiosensitivity of cancer cells
癌细胞体外放射敏感性公共大数据库
  • 批准号:
    20K16816
  • 财政年份:
    2020
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident
开发快速剂量测定系统,用于快速评估大规模放射事件受害者的急性辐射暴露、个体放射敏感性和损伤
  • 批准号:
    10089406
  • 财政年份:
    2020
  • 资助金额:
    $ 1.92万
  • 项目类别:
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident
开发快速剂量测定系统,用于快速评估大规模放射事件受害者的急性辐射暴露、个体放射敏感性和损伤
  • 批准号:
    10558479
  • 财政年份:
    2020
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了